1. Home
  2. RVSB vs PYXS Comparison

RVSB vs PYXS Comparison

Compare RVSB & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riverview Bancorp Inc

RVSB

Riverview Bancorp Inc

SELL

Current Price

$6.67

Market Cap

120.5M

Sector

Finance

ML Signal

SELL

Logo Pyxis Oncology Inc.

PYXS

Pyxis Oncology Inc.

SELL

Current Price

$1.42

Market Cap

141.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RVSB
PYXS
Founded
1923
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.5M
141.3M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
RVSB
PYXS
Price
$6.67
$1.42
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
★ $8.22
AVG Volume (30 Days)
55.5K
★ 742.5K
Earning Date
10-27-2026
11-05-2026
Dividend Yield
★ 1.20%
N/A
EPS Growth
N/A
★ 3.03
EPS
★ 0.18
N/A
Revenue
N/A
★ $13,858,000.00
Revenue This Year
$42.74
N/A
Revenue Next Year
$5.53
N/A
P/E Ratio
$82.63
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$4.88
$1.03
52 Week High
$6.67
$5.55

Technical Indicators

Market Signals
Indicator
RVSB
PYXS
Relative Strength Index (RSI) 80.18 29.90
Support Level $5.23 $1.29
Resistance Level N/A $1.77
Average True Range (ATR) 0.14 0.14
MACD 0.05 0.02
Stochastic Oscillator 98.72 0.87

Price Performance

Historical Comparison
RVSB
PYXS

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is the bank holding company. The Company's operations are managed along two operating segments, consisting of banking operations performed by the Bank and trust and investment services performed by the Trust Company. The Bank is engaged mainly in the business of attracting deposits from the general public and using such funds, together with other borrowings, to make various commercial business, commercial real estate, land, multi-family real estate, real estate construction and consumer loans. Additionally, the Trust Company offers trust and investment. Its operations into two operating segments, consisting of banking operations and trust and investment services, these operating segments are aggregated into a single reportable operating segment.

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a clinical-stage oncology company focused on developing therapies for patients with solid tumors, with an initial emphasis on head and neck squamous cell carcinoma. Its product candidate, micvotabart pelidotin (MICVO, formerly PYX-201), is an investigational antibody-drug conjugate that targets extradomain-B fibronectin (EDB+FN), a component of the tumor extracellular matrix that is expressed in tumors and minimally present in normal tissues. MICVO consists of a fully human monoclonal antibody linked to a microtubule inhibitor payload, designed to bind within the tumor microenvironment and release its payload to kill cancer cells directly, affect nearby cells through a bystander effect, and induce immunogenic cell death, supporting enhanced anti-tumor activity.

Share on Social Networks: